: epidemiology, genetic diversity and association with oral microbiota signatures in North Eastern Tanzania.

J Oral Microbiol

Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen S, Denmark.

Published: May 2021

Background: has been associated with periodontal diseases. Baseline data from the background population, which could help delimit the role of the parasite in health and disease, remain limited.

Objective: To describe epidemiological features, genetic diversity, and associations with oral microbiome signatures of colonisation in Tanzanians with non-oral/non-dental diseases.

Methods: DNAs from 92 oral washings from 52 participants were subject to metabarcoding of ribosomal genes. DNA sequences were identified to genus level and submitted to oral microbiota diversity analyses.

Results: Sixteen (31%) of the 52 study participants were positive, with no difference in positivity rate according to gender or age. Only one subtype (ST1) was found. Individuals testing positive for had higher oral microbiota alpha diversity than those testing negative ( = 0.03). Eight of the top-ten most common bacterial genera were shared between the two groups (, and . Meanwhile, carriers and non-carriers were more likely to have and , respectively, among the top-ten most common genera.

Conclusion: About one third of the cohort carried ST1, and carriers had higher oral microbiome diversity and were more predominantly colonized by .

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143617PMC
http://dx.doi.org/10.1080/20002297.2021.1924598DOI Listing

Publication Analysis

Top Keywords

oral microbiota
12
genetic diversity
8
oral microbiome
8
higher oral
8
top-ten common
8
oral
6
diversity
5
epidemiology genetic
4
diversity association
4
association oral
4

Similar Publications

The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications.

Mol Cancer

January 2025

Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, No. 20, Section 3, Renmin South Road, Chengdu, Sichuan Province, 610041, China.

The polymorphic microbiome is considered a new hallmark of cancer. Advances in High-Throughput Sequencing have fostered rapid developments in microbiome research. The interaction between cancer cells, immune cells, and microbiota is defined as the immuno-oncology microbiome (IOM) axis.

View Article and Find Full Text PDF

Nasal microbiota transplantation: a gateway to novel treatments.

Trends Microbiol

January 2025

Institute of Oral Biology, Faculty of Dentistry, University of Oslo, Norway. Electronic address:

Two recent studies have highlighted the potential of nasal microbiota transplantation (NMT) to treat chronic rhinosinusitis (CRS). Here we evaluate these findings and propose that lessons from fecal microbiota transplantation (FMT) could guide NMT development, with possible implications for combating antimicrobial resistance in respiratory infections.

View Article and Find Full Text PDF

Newly identified cell types crucial for gut commensal tolerance.

Trends Cell Biol

January 2025

Department of Immunology, Ophthalmology, and ENT, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12), Madrid, Spain. Electronic address:

The generation of regulatory T cells (Tregs) through interactions with antigen-presenting cells (APCs) is essential for establishing tolerance to gut commensals. Recent findings highlight the critical role of RORγt-lineage APCs, especially in gut-associated lymphoid tissues, in the induction of microbiota-specific peripheral Tregs and maintaining gut immune homeostasis.

View Article and Find Full Text PDF

Oral administration of Folium Artemisiae Argyi-derived exosome-like nanovesicles can improve ulcerative colitis by regulating intestinal microorganisms.

Phytomedicine

January 2025

General Surgery, Cancer Center, Department of Hepatobiliary & Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, PR China; Clinical Research Institute, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, PR China; Zhejiang Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, PR China; School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, PR China. Electronic address:

Background: Ulcerative colitis (UC), an inflammatory disease characterized by intestinal barrier dysfunction, poses significant challenges because of the toxicity and adverse effects commonly associated with conventional therapies. Safer and more efficacious treatment strategies are needed.

Purpose: The purpose of this study was to treat UC with Folium Artemisiae Argyi exosome-like nanovesicles (FAELNs) and to explore its related mechanism to provide a safer and more effective means for the treatment of ulcerative colitis.

View Article and Find Full Text PDF

Androgen deficiency-induced loss of Lactobacillus salivarius extracellular vesicles is associated with the pathogenesis of osteoporosis.

Microbiol Res

January 2025

Department of Rehabilitation Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, PR China; The Institute of Translational Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, PR China. Electronic address:

Male osteoporosis is primarily caused by a decrease in testicular testosterone production. Male osteoporosis remains a disease with insufficient diagnosis and treatment, and its consequences are severe, especially in older patients. The gut microbiota plays a crucial role in its occurrence and development.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!